Rocky Mountain spotted fever: case reports.

• Autor(a) principal: de Souza, Gabriel Alves
• Data de Publicação: 2023
• Outros Autores: Emericiano, Guilherme Martins Bezerra, Vásquez , Isabel Felipe, Fernandes, João Henrique Menezes, de Carvalho, Mateus Laurindo Ferreira, Santana, Vinícius Landim, da Silva, Cláudio Gleidiston Lima, de Lima, Marcos Antônio Pereira, dos Santos, Maria do Socorro Vieira
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Brazilian Journal of Implantology and Health Sciences
• Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/360
• topic: Febre Maculosa, Rickettsia, Doxiciclina, Relatos de caso.; Rocky Mountain spotted fever, Rickettsia, Doxycycline, Case reports

Spotted Fever (FM) is a disease caused by gram-negative bacteria of the Rickettsia species, transmitted through the bite of ticks of the Dermacentor variabilis and Dermacentor variabilis andersoni species, usually during the summer months. Thus, the present work aimed to review case reports on Rocky Mountain Spotted Fever, listing the main symptoms found, the most used diagnostic methods and the forms of treatment administered. A literature review was carried out in the PUBMED and Periódico da Capes databases, published from 2018 to 2023. In the analysis of the selected cases, it was found that the main clinical manifestations were fever, rash, myalgia, headache, asthenia, pain abdominal pain, arthralgia, edema and loss of consciousness. Regarding laboratory findings. the results of thrombocytopenia, transaminitis, leukopenia, hyponatremia and leukocytosis deserve to be highlighted. The main diagnostic tests used in the reports studied were indirect immunofluorescence (IFAT), PCR and the Weil-Felix test. In Brazil, the standard treatment is performed with doxycycline, with chloramphenicol used as a second choice and prioritized in severe forms, in which parenteral administration is necessary. In the general context, therapeutic management should be carried out early so that there are greater chances of cure for the patient with a reduction in mortality.